News

Planning for the fifth year of “Cataract Surgery: Telling It Like It Is,” set for Thursday, Jan. 15, to Sunday, Jan. 18, is well under way and meeting organizer Robert H. Osher, MD, promises “more faculty, more topics, and a lot more fireworks” for this latest gathering here.

Advances in imaging technology using swept-source microscope-integrated optical coherence tomography (OCT) provides detailed and three-dimensional volume images in real time, which cannot be obtained with conventional spectral-domain intraoperative OCT systems.

Analyses of data from patients treated for vitreomacular adhesion at a single center provide insights for management decisions and patient counseling.

Bausch + Lomb presented several product innovations in pharmaceuticals, OTC offerings, IOLs, and surgical devices and equipment during the annual meeting of the American Academy of Ophthalmology.

The results of the largest retrospective study of multiple sclerosis (MS) in uveitis patients has revealed that nearly 60% of patients with both diseases were diagnosed with each within a 5-year span.

A joint reception hosted by Ophthalmic Women Leaders (OWL) and Women in Ophthalmology (WIO) featured the presentation of the Suzanne Veronneau-Troutman Award to an outstanding female ophthalmologist. In addition, a panel discussion focused on the importance of working together across diverse professional disciplines in the eye-care field.

When misalignment of a toric IOL underlies a suboptimal outcome and the problem is identified during early postoperative follow-up, surgeons should not procrastinate about taking the patient back to the operating room for a repositioning procedure, said Roger F. Steinert, MD.

Data reported by American surgeons using ocriplasmin for treatment of symptomatic vitreomacular adhesion (VMA) show that it is possible to increase the success rate through careful patient selection, said David Chow, MD.

TearScience introduced its new LipiView II system that assists clinicians in improving diagnosis of meibomian gland dysfunction (MGD) with objective examination of patients’ tear film lipid layer, blink profile, and now meibomian gland structure and function.

Ellex Medical Lasers Ltd. has released a comprehensive e-book-“It’s All About Outflow”-describing the role of canaloplasty in clinical practice.

Findings from a mid-term evaluation of the first Descemet Membrane Endothelial Keratoplasty (DMEK) cohort show that the procedure results in a near complete visual recovery that is achieved at 6 months and seems to remain stable for at least up to 6 years, said Fook Chang Lam, MD.

Evidence for assessing the efficacy and safety of anti-vascular endothelial growth factor (VEGF) agents for treating corneal and ocular surface disease is accumulating. However, there is clearly a need for more research to define if, when, and how this therapy should be used, said Anat Galor, MD.

A targeted approach to treatment based on the findings of a thorough history, appropriate testing, and clinical exam can be successful for bringing relief to many patients with dry eye that is difficult to manage, said Deepinder K. Dhaliwal, MD.

As more state legislatures are relaxing anti-marijuana laws, doctors are being put in the middle by patients requesting prescriptions or authorizations for its use for medical needs, said Marc F. Lieberman, MD.